E
MDVL

Ergoteles’s MedAvail Holdings, Inc. Common Stock MDVL Stock Holding History

Ergoteles’s Portfolio MDVL Stock Details MDVL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-501
Closed -$38K – 2124
2022
Q2 		$38K Buy
+501
New +$43.9K ﹤0.01% 1568

Other funds holding MDVL

RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
AWGLSCP
ABG-WTT Global Life Science Capital Partners Central, Hong Kong, Hong Kong $12.3M AUM 3.13% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return
ABG
Ally Bridge Group New York $124M AUM 249.88% 1-Year Est. Return
CI
Cigna Investments Bloomfield, Connecticut $773M AUM 44.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
PVI
Pura Vida Investments New York $14.9M AUM 38.76% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Ergoteles's MDVL Position: Q3 2022 in Review

Ergoteles sold out of MedAvail Holdings, Inc. Common Stock (MDVL) in Q3 2022, closing a stake of 501 shares — an estimated $38K sold.

Ergoteles first reported a position in MDVL in Q2 2022 and held it in 1 quarter. The position peaked at $38K in Q2 2022. 32 funds tracked by Wall St. Rank hold MDVL as of Q3 2022.

  • Ergoteles reported no remaining MedAvail Holdings, Inc. Common Stock position as of Q3 2022 after selling out during the quarter.
  • Ergoteles sold 501 MedAvail Holdings, Inc. Common Stock shares in Q3 2022, an estimated $38K.
  • Ergoteles first reported a position in MedAvail Holdings, Inc. Common Stock in Q2 2022 and held it in 1 quarter.
  • Ergoteles's MedAvail Holdings, Inc. Common Stock position peaked at $38K in Q2 2022.
  • 32 funds tracked by Wall St. Rank held MedAvail Holdings, Inc. Common Stock as of Q3 2022.

Based on Ergoteles's 13F filing for Q3 2022, filed 14 Nov 2022.